Dhea (prasterone)
Generic Name: dhea (prasterone)
Dosage form: POWDER. Active ingredients: PRASTERONE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Overview
Dosage form: POWDER. Active ingredients: PRASTERONE (1 g/g). Category: BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING.
Dosage
Available as powder.
Related Medications
Imlunestrant
imlunestrant
Estrogen Receptor Antagonist [EPC]
11 DESCRIPTION INLURIYO tablets contain imlunestrant, an estrogen receptor antagonist. The chemical name for imlunestrant tosylate is (5R)-5-(4-(2-(3-(flouromethyl)azetidin-1-yl)ethoxy)phenyl)-8-(trifluoromethyl)-5H-( 1 )benzopyrano(4,3-c)quinolin-2-ol, tosylate salt (1:1). Imlunestrant tosylate is a white to practically white to yellow powder with the empirical formula C 29 H 24 F 4 N 2 O 3 .C 7 H 8 O 3 S and a molecular weight 696.71 g/mol.
Betibeglogene Autotemcel
betibeglogene autotemcel
11 DESCRIPTION ZYNTEGLO (betibeglogene autotemcel) is a β A-T87Q -globin gene therapy consisting of autologous CD34+ cells, containing hematopoietic stem cells (HSCs), transduced with BB305 LVV encoding β A-T87Q -globin, suspended in cryopreservation solution. ZYNTEGLO is intended for one-time administration to add functional copies of a modified form of the β-globin gene (β A-T87Q -globin gene) into the patient's own HSCs.
Lorcaserin Hydrochloride
lorcaserin hydrochloride
Dosage form: POWDER. Active ingredients: LORCASERIN HYDROCHLORIDE HEMIHYDRATE (1 kg/kg). Category: BULK INGREDIENT.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.